![Stephen Streeter](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Stephen Streeter
Direktor/Vorstandsmitglied bei Australian Technology Innovation Fund Ltd.
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Michael Monsour | M | - |
CBio Ltd.
![]() CBio Ltd. BiotechnologyHealth Technology CBio Ltd. focuses on developing new generation products for the treatment of autoimmune and inflammatory diseases. It develops and commercializes treatments for autoimmune diseases. The company focuses and develops technologies on commercializing its proprietary drug, XToll for autoimmune and inflammatory diseases. It develops technologies for the treatment of autoimmune and inflammatory diseases. The company also engages in the business of research, product development and clinical trials of the therapeutic drug XToll and development of variants to the company's Cpn10 technology. CBio was founded by Steve P. Jones on October 11, 2000 and is headquartered at Brisbane, Australia.
Australian Technology Innovation Fund Ltd.
![]() Australian Technology Innovation Fund Ltd. Financial ConglomeratesFinance Australian Technology Innovation Fund Ltd. is an investment company that is not classified elsewhere. | 5 Jahre |
Wayne A. Gooley | M | - |
Novus Capital Ltd.
![]() Novus Capital Ltd. Investment Banks/BrokersFinance Novus Capital Ltd. is a stockbroking and share trading service that specializes in capital raising, ASX IPO, corporate advice, reverse takeovers, and M&A. The private company is based in Sydney, Australia. and has subsidiaries in Cayman Islands. The Australian company was founded in 2001 by Wayne A. Gooley, who has been the CEO since 2001. | 23 Jahre |
Steve P. Jones | M | - |
Australian Technology Innovation Fund Ltd.
![]() Australian Technology Innovation Fund Ltd. Financial ConglomeratesFinance Australian Technology Innovation Fund Ltd. is an investment company that is not classified elsewhere. | - |
Sara Harman | F | - |
Novus Capital Ltd.
![]() Novus Capital Ltd. Investment Banks/BrokersFinance Novus Capital Ltd. is a stockbroking and share trading service that specializes in capital raising, ASX IPO, corporate advice, reverse takeovers, and M&A. The private company is based in Sydney, Australia. and has subsidiaries in Cayman Islands. The Australian company was founded in 2001 by Wayne A. Gooley, who has been the CEO since 2001. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Peter Corr | M | 76 |
CBio Ltd.
![]() CBio Ltd. BiotechnologyHealth Technology CBio Ltd. focuses on developing new generation products for the treatment of autoimmune and inflammatory diseases. It develops and commercializes treatments for autoimmune diseases. The company focuses and develops technologies on commercializing its proprietary drug, XToll for autoimmune and inflammatory diseases. It develops technologies for the treatment of autoimmune and inflammatory diseases. The company also engages in the business of research, product development and clinical trials of the therapeutic drug XToll and development of variants to the company's Cpn10 technology. CBio was founded by Steve P. Jones on October 11, 2000 and is headquartered at Brisbane, Australia. | 4 Jahre |
Roger Smeed | M | 69 | 2 Jahre | |
John Watson Funder | M | - |
CBio Ltd.
![]() CBio Ltd. BiotechnologyHealth Technology CBio Ltd. focuses on developing new generation products for the treatment of autoimmune and inflammatory diseases. It develops and commercializes treatments for autoimmune diseases. The company focuses and develops technologies on commercializing its proprietary drug, XToll for autoimmune and inflammatory diseases. It develops technologies for the treatment of autoimmune and inflammatory diseases. The company also engages in the business of research, product development and clinical trials of the therapeutic drug XToll and development of variants to the company's Cpn10 technology. CBio was founded by Steve P. Jones on October 11, 2000 and is headquartered at Brisbane, Australia. | 4 Jahre |
James Greig | M | - |
CBio Ltd.
![]() CBio Ltd. BiotechnologyHealth Technology CBio Ltd. focuses on developing new generation products for the treatment of autoimmune and inflammatory diseases. It develops and commercializes treatments for autoimmune diseases. The company focuses and develops technologies on commercializing its proprietary drug, XToll for autoimmune and inflammatory diseases. It develops technologies for the treatment of autoimmune and inflammatory diseases. The company also engages in the business of research, product development and clinical trials of the therapeutic drug XToll and development of variants to the company's Cpn10 technology. CBio was founded by Steve P. Jones on October 11, 2000 and is headquartered at Brisbane, Australia. | 5 Jahre |
Zoe Yan Zhang | F | 57 | 2 Jahre | |
Göran Albert Ando | M | 75 |
CBio Ltd.
![]() CBio Ltd. BiotechnologyHealth Technology CBio Ltd. focuses on developing new generation products for the treatment of autoimmune and inflammatory diseases. It develops and commercializes treatments for autoimmune diseases. The company focuses and develops technologies on commercializing its proprietary drug, XToll for autoimmune and inflammatory diseases. It develops technologies for the treatment of autoimmune and inflammatory diseases. The company also engages in the business of research, product development and clinical trials of the therapeutic drug XToll and development of variants to the company's Cpn10 technology. CBio was founded by Steve P. Jones on October 11, 2000 and is headquartered at Brisbane, Australia. | 4 Jahre |
Dennis J. Feeney | M | - |
CBio Ltd.
![]() CBio Ltd. BiotechnologyHealth Technology CBio Ltd. focuses on developing new generation products for the treatment of autoimmune and inflammatory diseases. It develops and commercializes treatments for autoimmune diseases. The company focuses and develops technologies on commercializing its proprietary drug, XToll for autoimmune and inflammatory diseases. It develops technologies for the treatment of autoimmune and inflammatory diseases. The company also engages in the business of research, product development and clinical trials of the therapeutic drug XToll and development of variants to the company's Cpn10 technology. CBio was founded by Steve P. Jones on October 11, 2000 and is headquartered at Brisbane, Australia. | 7 Jahre |
Terje Kalland | M | 73 |
CBio Ltd.
![]() CBio Ltd. BiotechnologyHealth Technology CBio Ltd. focuses on developing new generation products for the treatment of autoimmune and inflammatory diseases. It develops and commercializes treatments for autoimmune diseases. The company focuses and develops technologies on commercializing its proprietary drug, XToll for autoimmune and inflammatory diseases. It develops technologies for the treatment of autoimmune and inflammatory diseases. The company also engages in the business of research, product development and clinical trials of the therapeutic drug XToll and development of variants to the company's Cpn10 technology. CBio was founded by Steve P. Jones on October 11, 2000 and is headquartered at Brisbane, Australia. | 1 Jahre |
Thomas Lönngren | M | 73 |
CBio Ltd.
![]() CBio Ltd. BiotechnologyHealth Technology CBio Ltd. focuses on developing new generation products for the treatment of autoimmune and inflammatory diseases. It develops and commercializes treatments for autoimmune diseases. The company focuses and develops technologies on commercializing its proprietary drug, XToll for autoimmune and inflammatory diseases. It develops technologies for the treatment of autoimmune and inflammatory diseases. The company also engages in the business of research, product development and clinical trials of the therapeutic drug XToll and development of variants to the company's Cpn10 technology. CBio was founded by Steve P. Jones on October 11, 2000 and is headquartered at Brisbane, Australia. | - |
Julia Yan Zhu | F | 59 | 4 Jahre | |
Zeng Li | M | 60 | 2 Jahre | |
Zhi Qing Vincent Zhu | M | - | 2 Jahre | |
Zhou Simon Zhuang | M | - | 2 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Australien | 17 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Stephen Streeter
- Persönliches Netzwerk